Skip to content
DefDex
USIL Therapeutics S.A. logo

Startup · Luxembourg

USIL Therapeutics S.A.

HQ Luxembourg, LuxembourgFounded 20251-10 employeesUpdated

Deployable medical countermeasures against Acute Radiation Syndrome.

StartupBiotechnology and biomanufacturingCBRN defense and security screening
Website
Total raised
Undisclosed
1 round
Last round
~$6.1M
Grant · May 5, 2026
Systems
2
Capabilities
2

Funding1 round

Equity raised
Undisclosed
Debt, secondaries & grants
~$6.1M
Latest
~$6.1MGrant · May 5, 2026
  • Grant
    ~$6.1M
    May 5, 2026

Raised counts equity rounds; debt, secondary sales and grants are totaled separately. Amounts in other currencies are converted at the announcement month's average rate. A ~ marks an estimated or converted amount.

Systems2

  • UT-241An auto-injector formulation intended for radiation-response applications.
    —
  • UT-242An intravenous formulation intended for post-event radiation-response applications.
    —

Newest unveiled first. Systems that belong to a government program link to the program page, where variants, costs and contracts are.

Capabilities2

  • Biotechnology and biomanufacturing
    Developer
    classify_sectors run 37, sonnet, taxonomy 2026-10-18b: Deployable medical countermeasures against Acute Radiation Syndrome.
    —Reported
  • CBRN defense and security screening
    Developer
    classify_sectors run 37, sonnet, taxonomy 2026-10-18b: Deployable medical countermeasures against Acute Radiation Syndrome.
    —Reported

Maturity and TRL describe this organization's work; the field-wide maturity is on each technology's page.

People5

All 5 people →
People
PersonRole
Bruno FlamionFounder
Bruno Le GrandFounder
Frederic MarinFounder
Michel AndraudFounder
Valentin WiedlingFounder

Sources6

Profile3

  1. 1
    DatabaseUSIL Therapeutics company information, funding & investors

    directory.startupluxembourg.com · Supports Organization · founded year

    “HQ location Luxembourg, Luxembourg Website Launch date 2025”
  2. 2
    CompanyJoin the next cohort for the EU-wide Defence Business Accelerator powered by the European Commission

    EUDIS Business Accelerator · Supports Organization

    “The EUDIS Business Accelerator supports a cohort of 20 startups and scaleups”
  3. 3
    CompanyCohort

    EUDIS Business Accelerator · Supports Organization

    “USIL Therapeutics S.A. … Deployable medical countermeasures against Acute Radiation Syndrome”

Systems1

  1. 4
    CompanyAdvancing Human Resilience to Radiation.

    USIL Therapeutics · Supports Organization · name, System

    “USIL Therapeutics addresses a critical capability gap in nuclear and radiological preparedness across defence, civilian, aerospace, and space domains.”

Funding1

  1. 5
    CompanyUSIL Therapeutics S.A. | LinkedIn

    LinkedIn · Supports Funding round, Organization · ownership

    “funding round: Grant, 2026-05-05, EUR 5,200,000, lead: European Commission”

People1

  1. 6
    DatabaseUSIL Therapeutics S.A. — headquarters location

    Crunchbase via Bright Data · Supports Organization · headquarters, Organization · num employees, Role · founders

    “{"country_code": "Luxembourg", "location": [{"name": "Luxembourg", "permalink": "luxembourg-luxembourg"}, {"name": "Luxembourg", "permalink": "luxembourg-luxembourg-1bf1"}, {"name": "Luxembourg", "permalink": "luxembourg"}, {"name": "Europe", "permalink": "europe"}]}”

Each fact on this page is attached to the sources that support it. Archived copies are linked when we keep one.